Skip to main content
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 2007 Sep 10;21(5):335–339. doi: 10.1002/jcla.20193

Insulin‐like growth factor I (IGF‐I) as a sensitive biomarker of catabolism in patients with gastrointestinal diseases

Olgica Nedić 1,✉, Vesna Malenković 2, Judith Anna Nikolić 1, Ivona Baričević 1
PMCID: PMC6649162  PMID: 17847115

Abstract

Gastrointestinal ailments evoke changes in the hypothalamic‐pituitary‐adrenal (HPA) axis and modulation of hepatic protein synthesis. We examined the catabolic effect of certain primary gastrointestinal diseases and surgery on the concentration of insulin‐like growth factor I (IGF‐I). Blood samples from patients with gastric cancer (GC), cholecystitis (CC), or inguinal hernia (IH) were taken before and after surgery. The concentrations of IGF‐I, IGF binding protein‐1 (IGFBP‐1), insulin, cortisol, and glucose were determined. In GC patients the concentration of IGF‐I was reduced and the concentrations of IGFBP‐1 and cortisol were elevated preoperatively; after surgery, IGFBP‐1 normalized. In CC patients the concentration of IGF‐I was low and the concentration of IGFBP‐1 was high before cholecystectomy; after surgery IGFBP‐1 returned to normal and the concentration of cortisol increased. In IH patients the concentration of IGF‐I was low and the concentrations of IGFBP‐1 and cortisol were high before surgery; after laparotomy IGFBP‐1 returned to normal. The metabolic changes were present in all analyzed patient groups, regardless of the severity of disease and nutrition. The concentration of IGF‐I was reduced before surgery and remained reduced after, recommending IGF‐I as a metabolic marker in both pre and postoperative examination of patients. J. Clin. Lab. Anal. 21:335–339, 2007. © 2007 Wiley‐Liss, Inc.

Keywords: IGF‐I, metabolism, gastric cancer, cholecystitis, inguinal hernia

REFERENCES

  • 1. Gruys E, Toussaint MJM, Niewold TA, Koopmans SJ. Acute phase reaction and acute phase proteins. J Zhejiang Univ Sci 2005;6B:1045–1056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Yuen KCJ, Dunger DB. Impact of treatment with recombinant human GH and IGF‐I on visceral adipose tissue and glucose homeostasis in adults. Growth Horm IGF Res 2006;16:S55–S61. [DOI] [PubMed] [Google Scholar]
  • 3. Juul A. Serum levels of insulin‐like growth factor I and its binding proteins in health and disease. Growth Horm IGF Res 2003;13:113–170. [DOI] [PubMed] [Google Scholar]
  • 4. Hwang DL, Huang SP, Lan WS, Lee PDK. Elevated insulin, proinsulin and insulin‐like growth factor‐binding protein‐1 in liver disease. Growth Horm IGF Res 2003;13:316–321. [DOI] [PubMed] [Google Scholar]
  • 5. Thomas DR, Zdrowski CD, Wilson MM, et al. Malnutrition in subacute care. Am J Clin Nutr 2002;75:308–313. [DOI] [PubMed] [Google Scholar]
  • 6. International Federation of Clinical Chemistry Scientific Committee, Clinical Section Expert Panel on Theory of Reference Values and International Committee for Standardisation in Haematology . Part 5. Statistical treatment on the theory of reference values: determination of reference limits. J Clin Chem Clin Biochem 1987;25:645–656. [Google Scholar]
  • 7. Nedić O, Miloradović J, Ratković M, Masnikosa R. Insulin and C‐peptide response in healthy persons and individuals with impaired glucose metabolism during oral glucose tolerance test. Jugoslov Med Biohem 2005;24:35–39. [Google Scholar]
  • 8. Gianotti L, Broglio F, Aimaretti G, et al. Low IGF‐I levels are often uncoupled with elevated GH levels in catabolic conditions. J Endocrinol Invest 1998;21:115–121. [DOI] [PubMed] [Google Scholar]
  • 9. Cotterill AM, Mendel P, Holly JM, et al. The differential regulation of the circulating levels of the insulin‐like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective surgery. Clin Endocrinol 1996;44:91–101. [DOI] [PubMed] [Google Scholar]
  • 10. Baxter RC, Hawker FH, To C, Stewart PM, Holman SR. Thirty‐day monitoring of insulin‐like growth factors and their binding proteins in intensive care unit patients. Growth Horm IGF Res 1998;8:455–463. [DOI] [PubMed] [Google Scholar]
  • 11. Timmins AC, Cotterill AM, Hughes SC, et al. Critical illness is associated with low circulating concentrations of insulin‐like growth factor binding proteins, and induction of an insulin‐like growth factor binding protein protease. Crit Care Med 1996;24:1460–1466. [DOI] [PubMed] [Google Scholar]
  • 12. Baričević I, Jones DR, Malenković V, Nedić O. The effect of laparoscopy on the IGF system in patients diagnosed with acute cholecystitis. Clin Endocrinol 2006;65:373–379. [DOI] [PubMed] [Google Scholar]
  • 13. Baričević I, Jones DR, Nikolić JA, Nedić O. Gastrointestinal inflammation and the circulating IGF system in humans. Horm Metab Res 2006;38:22–27. [DOI] [PubMed] [Google Scholar]
  • 14. Eivindson M, Grønbćk H, Flyvbjerg A, Frystuk J, Zimmermann‐Nielsen E, Dahlerup JF. The insulin‐like growth factor (IGF) system in active ulcerative colitis and Crohn's disease: relations to disease activity and corticosteroid treatment. Growth Horm IGF Res 2007;17:33–40. [DOI] [PubMed] [Google Scholar]
  • 15. Khosravi J, Krishna RG, Bodani U, et al. Immunoassay of serine‐phosphorylated isoform of insulin‐like growth factor (IGF) binding protein (IGFBP)‐1. Clin Biochem 2007;40:86–93. [DOI] [PubMed] [Google Scholar]
  • 16. Isley WL, Underwood LE, Clemmons DR. Dietary components that regulate serum somatomedin‐C concentrations in humans. J Clin Invest 1983;71:175–182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Smith J, Underwood LE, Clemmons DR. Effects of caloric or protein restriction on insulin‐like growth factor‐I (IGF‐I) and IGF‐binding proteins in children and adults. J Clin Endocrinol Metab 1995;80:443–449. [DOI] [PubMed] [Google Scholar]
  • 18. Hildebrand F, Pape HC, Krettek C. The importance of cytokines in the posttraumatic inflammatory reaction. Unfallchirurg 2005;108:796–803. [DOI] [PubMed] [Google Scholar]
  • 19. Lee DY, Yang DH, Kang CW, et al. Serum insulin‐like growth factors (IGFs) and IGF binding protein (IGFBP)‐3 in patients with gastric cancer: IGFBP‐3 protease activity induced by surgery. J Korean Med Sci 1997;12:32–39. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES